Drug Type Synthetic peptide |
Synonyms HBP08 |
Target |
Mechanism HMGB1 inhibitors(High Mobility Group Protein B1 inhibitors), SDF-1 antagonists(C-X-C motif chemokine ligand 12 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | CH | 23 Sep 2021 |